Bayer AG
OTC:BAYZF

Watchlist Manager
Bayer AG Logo
Bayer AG
OTC:BAYZF
Watchlist
Price: 45.33 USD -1.09% Market Closed
Market Cap: 44.5B USD

Relative Value

The Relative Value of one BAYZF stock under the Base Case scenario is hidden USD. Compared to the current market price of 45.33 USD, Bayer AG is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

BAYZF Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
55
vs Industry
83
Median 3Y
0.6
Median 5Y
1
Industry
2.7
Forward
0.8
vs History
vs Industry
40
Median 3Y
-8.6
Median 5Y
-6.7
Industry
21.6
Forward
8.1
vs History
60
vs Industry
50
Median 3Y
4.3
Median 5Y
7.3
Industry
16.9
vs History
14
vs Industry
31
Median 3Y
8.9
Median 5Y
8.6
Industry
22.9
vs History
44
vs Industry
67
Median 3Y
0.9
Median 5Y
1.3
Industry
2.3
vs History
53
vs Industry
68
Median 3Y
1.2
Median 5Y
1.5
Industry
3
Forward
1.4
vs History
49
vs Industry
71
Median 3Y
2.1
Median 5Y
2.5
Industry
5.6
vs History
12
vs Industry
45
Median 3Y
6.1
Median 5Y
6.4
Industry
13.4
Forward
6.6
vs History
4
vs Industry
17
Median 3Y
13.3
Median 5Y
11.3
Industry
16.7
Forward
10.1
vs History
61
vs Industry
46
Median 3Y
8.7
Median 5Y
11.4
Industry
16.1
vs History
47
vs Industry
32
Median 3Y
11.7
Median 5Y
15.7
Industry
18.9
vs History
34
vs Industry
72
Median 3Y
0.6
Median 5Y
0.7
Industry
2

Multiples Across Competitors

BAYZF Competitors Multiples
Bayer AG Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
DE
Bayer AG
OTC:BAYZF
38.2B USD 0.8 -192.9 10.4 33
US
Eli Lilly and Co
NYSE:LLY
1T USD 16.9 54.6 36.7 39.3
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
491.8B USD 5.3 19.6 16 20.8
CH
Roche Holding AG
SIX:ROG
271.4B CHF 4.4 28.8 12.2 14.3
UK
AstraZeneca PLC
LSE:AZN
220.4B GBP 5.1 31.4 108.8 159.2
US
Merck & Co Inc
NYSE:MRK
274.9B USD 4.3 14.4 10.2 12.1
CH
Novartis AG
SIX:NOVN
218.8B CHF 4.9 19 12 15.5
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK 5.4 16.3 11.3 13.2
IE
Endo International PLC
LSE:0Y5F
213.9B USD 92.2 -73.2 338.7 849.2
US
Pfizer Inc
NYSE:PFE
144.9B USD 2.3 14.7 7.5 10.2
P/E Multiple
Earnings Growth PEG
DE
Bayer AG
OTC:BAYZF
Average P/E: 24.9
Negative Multiple: -192.9
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
54.6
54%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
19.6
29%
0.7
CH
Roche Holding AG
SIX:ROG
28.8
29%
1
UK
AstraZeneca PLC
LSE:AZN
31.4
37%
0.8
US
Merck & Co Inc
NYSE:MRK
14.4
15%
1
CH
Novartis AG
SIX:NOVN
19
17%
1.1
DK
Novo Nordisk A/S
CSE:NOVO B
16.3
3%
5.4
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -73.2 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.7
27%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
DE
Bayer AG
OTC:BAYZF
Average EV/EBITDA: 400.9
10.4
-7%
N/A
US
Eli Lilly and Co
NYSE:LLY
36.7
34%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16
9%
1.8
CH
Roche Holding AG
SIX:ROG
12.2
5%
2.4
UK
AstraZeneca PLC
LSE:AZN
108.8
10%
10.9
US
Merck & Co Inc
NYSE:MRK
10.2
6%
1.7
CH
Novartis AG
SIX:NOVN
12
6%
2
DK
Novo Nordisk A/S
CSE:NOVO B
11.3
1%
11.3
IE
E
Endo International PLC
LSE:0Y5F
338.7
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.5
0%
N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
DE
Bayer AG
OTC:BAYZF
Average EV/EBIT: 1 715.4
33
21%
1.6
US
Eli Lilly and Co
NYSE:LLY
39.3
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
20.8
15%
1.4
CH
Roche Holding AG
SIX:ROG
14.3
6%
2.4
UK
AstraZeneca PLC
LSE:AZN
159.2
23%
6.9
US
Merck & Co Inc
NYSE:MRK
12.1
8%
1.5
CH
Novartis AG
SIX:NOVN
15.5
12%
1.3
DK
Novo Nordisk A/S
CSE:NOVO B
13.2
0%
N/A
IE
E
Endo International PLC
LSE:0Y5F
849.2
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.2
7%
1.5